| PurposeTaking Tongmai Oral Liquid as a matched control by vein and Tongtian Oral Liquid as a treatment set, this topic plan objectively evaluates the usefulness and safety of the latter to treat stroke recovery (Congestion resistance Tongxinluo due to Wind), through the stochastic, double-blind, contra positive in parallel experimentation.MethodThe pilot used a randomized, double-blind, the treatment group and control group of parallel control of the research methods. Of 60 cases of stroke recovery, TCM is bleeding Congestion resistance Tongxinluo due to Wind-impacted by the patients admitted to hospital priorities, a randomized, double-blind, parallel control test, divided into Group A and Group B, of which 45 cases of group A, B Group 15, entered the double-blind period. All the subjects were in use before and after treatment 1, 2, 3, 4-week evaluation and filled out a case report form (CRF), to provide the Forum efficacy and safety of oral liquid assessment of the data and information. The entire clinical trial of four weeks.Evaluation criteria:①Major evaluation indicators: the degree of neurological deficit and the effect of invalidity determine the extent (efficient judgment: the basic recovery, significant progress and advancement as effective);②Secondary evaluation indicators: TCM to be in effect Hou;③Safety Evaluation criteria: before and after treatment blood, urine routine, conventional and liver and kidney function will and determination of ECG.After the completion of the pilot , it used SAS 6.12 statistical analysis software to the final statistical analysis. ConclusionTongtian Liquid treatment of ischemic stroke recovery significant effect, and the treatment of oral Tongmai Liquid there was no significant difference, and no apparent adverse reactions and side effects. TT can significantly improve symptoms in patients with Chinese medicine and promote neurological recovery, improve the quality of life of patients. |
PDF Full Text Request